• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人骨与软组织肿瘤中肝细胞生长因子(HGF)与c-Met/HGF受体的共表达

Coexpression of HGF and c-Met/HGF receptor in human bone and soft tissue tumors.

作者信息

Fukuda T, Ichimura E, Shinozaki T, Sano T, Kashiwabara K, Oyama T, Nakajima T, Nakamura T

机构信息

Second Department of Pathology, Gunma University School of Medicine, Maebashi, Japan.

出版信息

Pathol Int. 1998 Oct;48(10):757-62. doi: 10.1111/j.1440-1827.1998.tb03834.x.

DOI:10.1111/j.1440-1827.1998.tb03834.x
PMID:9788258
Abstract

To understand the interaction between hepatocyte growth factor (HGF) and its receptor c-Met on various bone and soft tissue tumors, their expressions were investigated by western blot analysis, immunohistochemistry and enzyme immunoassay. Western blot analysis revealed that c-Met protein was expressed in 21 (38.8%) of 54 tumors, which detailed to seven (25.9%) of 27 bone tumors and 14 (51.8%) of 27 soft tissue tumors. Most malignant fibrous histiocytomas (MFH) and all neurofibromas expressed c-Met protein. The highest expression of c-Met protein was seen in a case of biphasic synovial sarcoma, where its immunoreactivity was localized only on the epithelial component and not on the sarcomatous component. By enzyme immunoassay for HGF, all but one MFH showed HGF production and the mean level of HGF was the highest among the tumors investigated. Neurofibromas and osteosarcomas had the next highest mean levels of HGF production, respectively. Coexpression of HGF and c-Met was observed in 19 (35.2%) of 54 tumors and was frequently observed in neurofibroma, followed by MFH and synovial sarcoma. Although the mode of interaction between HGF and c-Met varies among the various bone and soft tissue tumors including MFH, their signaling system may play an important role in the development and progression of bone and soft tissue tumors.

摘要

为了解肝细胞生长因子(HGF)及其受体c-Met在各种骨和软组织肿瘤中的相互作用,通过蛋白质印迹分析、免疫组织化学和酶免疫测定法对它们的表达进行了研究。蛋白质印迹分析显示,54个肿瘤中有21个(38.8%)表达c-Met蛋白,其中27个骨肿瘤中有7个(25.9%),27个软组织肿瘤中有14个(51.8%)。大多数恶性纤维组织细胞瘤(MFH)和所有神经纤维瘤均表达c-Met蛋白。在一例双相滑膜肉瘤中观察到c-Met蛋白的最高表达,其免疫反应性仅定位于上皮成分,而非肉瘤成分。通过对HGF的酶免疫测定,除一个MFH外,所有MFH均显示有HGF产生,且HGF的平均水平在所研究的肿瘤中最高。神经纤维瘤和骨肉瘤的HGF产生平均水平分别次之。在54个肿瘤中有19个(35.2%)观察到HGF和c-Met的共表达,且在神经纤维瘤中经常观察到,其次是MFH和滑膜肉瘤。尽管HGF和c-Met之间的相互作用模式在包括MFH在内的各种骨和软组织肿瘤中有所不同,但其信号系统可能在骨和软组织肿瘤的发生和发展中起重要作用。

相似文献

1
Coexpression of HGF and c-Met/HGF receptor in human bone and soft tissue tumors.人骨与软组织肿瘤中肝细胞生长因子(HGF)与c-Met/HGF受体的共表达
Pathol Int. 1998 Oct;48(10):757-62. doi: 10.1111/j.1440-1827.1998.tb03834.x.
2
Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.肝细胞生长因子(HGF)受体(Met)在局部侵袭性/恶性人类肌肉骨骼肿瘤中过表达,且存在截短并激活的细胞内HGF受体片段。
Am J Pathol. 2000 Mar;156(3):821-9. doi: 10.1016/S0002-9440(10)64950-4.
3
Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma.肝细胞生长因子与c-Met原癌基因产物在滑膜肉瘤中的共表达。
Pathol Int. 1998 Oct;48(10):769-75. doi: 10.1111/j.1440-1827.1998.tb03836.x.
4
Coexpression of hepatocyte growth factor and its receptor c-Met correlates with high MIB-1 proliferative index in malignant fibrous histiocytoma.肝细胞生长因子及其受体c-Met的共表达与恶性纤维组织细胞瘤中高MIB-1增殖指数相关。
Pathol Res Pract. 2004;200(5):397-402. doi: 10.1016/j.prp.2004.03.007.
5
Expression of c-Met receptor and hepatocyte growth factor/scatter factor in synovial sarcoma and epithelioid sarcoma.c-Met受体和肝细胞生长因子/散射因子在滑膜肉瘤和上皮样肉瘤中的表达
Virchows Arch. 1998 Apr;432(4):337-42. doi: 10.1007/s004280050175.
6
The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study.未分类的多形性肉瘤/恶性纤维组织细胞瘤(UPS/MFH)中 c-Met 通路成分的表达:一项组织微阵列研究。
Histopathology. 2011 Sep;59(3):556-61. doi: 10.1111/j.1365-2559.2011.03946.x.
7
Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.c-原癌基因产物(c-MET)在良性和恶性骨肿瘤中的表达。
Mod Pathol. 1997 Aug;10(8):832-8.
8
Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.Met/肝细胞生长因子受体基因表达与肌肉骨骼肿瘤的恶性行为
Am J Pathol. 1996 Oct;149(4):1209-19.
9
Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.肝细胞生长因子和原癌基因受体c-Met在犬骨肉瘤中的表达
Vet Pathol. 2009 Sep;46(5):869-77. doi: 10.1354/vp.08-VP-0155-F-FL. Epub 2009 May 9.
10
Expression of osteopontin and HGF/met in adult soft tissue tumors.骨桥蛋白和HGF/met在成人软组织肿瘤中的表达
Cancer Biol Ther. 2005 Dec;4(12):1336-41. doi: 10.4161/cbt.4.12.2166. Epub 2005 Dec 9.

引用本文的文献

1
Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa.骨肉瘤中的酪氨酸激酶抑制剂:调整治疗策略a。
J Bone Oncol. 2023 Nov 3;43:100511. doi: 10.1016/j.jbo.2023.100511. eCollection 2023 Dec.
2
High Prevalence of 5T4/Trophoblast Glycoprotein in Soft Tissue Sarcomas.软组织肉瘤中5T4/滋养层糖蛋白的高患病率。
Cancers (Basel). 2021 Sep 28;13(19):4841. doi: 10.3390/cancers13194841.
3
Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.
神经纤维瘤病 1 型(NF1)相关周围神经系统肿瘤的诊断和发病机制的最新进展。
Adv Anat Pathol. 2018 Sep;25(5):353-368. doi: 10.1097/PAP.0000000000000197.
4
Genomic Status of Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors.NF1 相关恶性外周神经鞘瘤中基因组状态增强对 MET 和 MEK 抑制的敏感性。
Cancer Res. 2018 Jul 1;78(13):3672-3687. doi: 10.1158/0008-5472.CAN-17-3167. Epub 2018 May 2.
5
miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.miR-152 下调与 leiomyosarcoma 和 undifferentiated pleomorphic sarcoma 中的 MET 上调相关。
Cell Oncol (Dordr). 2017 Feb;40(1):77-88. doi: 10.1007/s13402-016-0306-4. Epub 2016 Nov 29.
6
Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.肝细胞生长因子/c-MET信号通路在滑膜肉瘤中的功能及治疗相关性
Cancer Sci. 2016 Dec;107(12):1867-1876. doi: 10.1111/cas.13092. Epub 2016 Dec 19.
7
The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma.肝细胞生长因子受体作为去分化脂肪肉瘤的潜在治疗靶点。
Lab Invest. 2015 Aug;95(8):951-61. doi: 10.1038/labinvest.2015.62. Epub 2015 Jun 1.
8
Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma.联合靶向mTOR和c-MET信号通路以有效治疗上皮样肉瘤
Mol Cancer. 2014 Aug 7;13:185. doi: 10.1186/1476-4598-13-185.
9
Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.Trp53单倍体不足改变了表皮生长因子受体驱动的周围神经鞘瘤发生。
Am J Pathol. 2014 Jul;184(7):2082-98. doi: 10.1016/j.ajpath.2014.04.006. Epub 2014 May 13.
10
Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines.多种受体酪氨酸激酶促进转移性人骨肉瘤细胞系的体外表型。
Oncogenesis. 2012 Nov 19;1(11):e34. doi: 10.1038/oncsis.2012.34.